Aurora Cannabis (TSE:ACB) Reaches New 12-Month Low at $4.61

Aurora Cannabis Inc (TSE:ACB) shares hit a new 52-week low on Monday . The stock traded as low as C$4.61 and last traded at C$4.67, with a volume of 1927146 shares traded. The stock had previously closed at C$4.81.

Several brokerages have weighed in on ACB. CIBC reaffirmed a “neutral” rating and set a C$7.00 price target on shares of Aurora Cannabis in a research report on Tuesday, September 24th. Jefferies Financial Group dropped their target price on Aurora Cannabis from C$14.00 to C$7.00 in a research report on Friday, October 11th. Stifel Nicolaus cut Aurora Cannabis from a “hold” rating to a “sell” rating and dropped their target price for the company from C$7.00 to C$5.00 in a research report on Monday, September 16th. Finally, Desjardins dropped their target price on Aurora Cannabis from C$16.50 to C$14.00 and set a “buy” rating on the stock in a research report on Friday, September 13th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. Aurora Cannabis currently has a consensus rating of “Hold” and an average target price of C$11.00.

The company has a current ratio of 1.52, a quick ratio of 0.98 and a debt-to-equity ratio of 14.69. The stock has a market capitalization of $4.88 billion and a price-to-earnings ratio of -16.14. The stock has a 50-day moving average price of C$6.50 and a 200 day moving average price of C$9.27.

About Aurora Cannabis (TSE:ACB)

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Article: Market Capitalization

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with's FREE daily email newsletter.